CXCL9 and prostate carcinoma: Furthermore, chemokine CXCL9 secreted by the prostate cancer cells was shown to mediate CD4+ T cell recruitment to the prostate cancer regions, and CXCL9 blockage suppressed CD4+T cell migration towards the prostate cancer cells.